| | |
| Clinical data | |
|---|---|
| Drug class | Serotonin 5-HT2A receptor agonist |
| ATC code |
|
| Identifiers | |
| |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C18H21N3O2S |
| Molar mass | 343.45 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Z2876442907, is a tryptamine derivative which acts as a serotonin 5-HT2A receptor agonist. It was discovered from a molecule docking screen against the AlphaFold model of the 5-HT2A receptor. As its 5-HT2A agonist activity has only been established in vitro, it is not yet established whether it produces psychedelic effects in animal models. It is structurally similar to other 5-HT2A agonist tryptamine derivatives such as 5-MeO-T-NBOMe and NEtPhOH-THPI, as well as the 5-HT6 antagonist idalopirdine. [1]